Physician profile
Ryan A Stanton
NPI 1811044597
$83,107.94
in general payments reported to CMS, 2019-2025
16 companies · $20K in 2025
The $20K reported for 2025 was more than what 99% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $5,623 · 2021: $12K · 2022: $13K · 2023: $7,931 · 2024: $5,833 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $6,153 · Consulting Fee: $5,700 · Food and Beverage: $1,309 · Grant: $1,000 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,037.50 |
| Travel and Lodging | $6,152.63 |
| Consulting Fee | $5,700.00 |
| Food and Beverage | $1,309.34 |
| Grant | $1,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $74,656.57 | 2019-2025 | Arrow |
| Arrow International, INC. | $3,733.14 | 2019 | |
| Genzyme Corporation | $1,500.00 | 2025 | |
| Abbott Laboratories | $632.13 | 2022-2023 | I-Stat |
| Astrazeneca Pharmaceuticals LP | $526.75 | 2019-2024 | Andexxa |
| Vapotherm INC | $517.74 | 2019-2023 | Vapotherm |
| E.R. Squibb & Sons, L.L.C. | $500.00 | 2025 | |
| Mindray Ds USA, INC. | $261.83 | 2022 | |
| Ekos Corporation | $245.72 | 2019 | |
| Inari Medical, INC. | $143.67 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alexion Pharmaceuticals, INC. | $107.51 | 2021 | |
| Pfizer INC. | $97.74 | 2019-2021 | |
| Btg International INC. | $70.67 | 2025 | Aurlumyn |
| Janssen Pharmaceuticals, INC | $65.80 | 2019-2023 | Xarelto |
| Allergan, INC. | $28.71 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $19.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Stanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.